article · Medical Reports
A 78-year-old woman presented with chronic pelvic pain, abdominal distension, and a mobile mass suggestive of ovarian malignancy. Imaging studies, including MRI, revealed a malignant-appearing ovarian mass with abundant ascites, and serum CA125 levels were significantly elevated. During surgery, a total hysterectomy with bilateral anexectomy was performed due to the tumor’s malignant features. Postoperative histopathology identified the mass as a fibro-thecoma, a rare benign ovarian tumor often misdiagnosed as malignant. The surgical intervention was curative, and no adjuvant therapy was required. This case underscores the diagnostic challenges associated with fibro-thecoma, emphasizing the importance of preoperative evaluation, intraoperative assessment, and the role of radical surgery in achieving optimal outcomes. It also highlights the need for distinguishing Demons-Meigs syndrome from advanced ovarian malignancies. • Case Overview: A 78-year-old woman presented with chronic pelvic pain, abdominal distension, and a mobile mass suggestive of ovarian malignancy. Imaging studies revealed a malignant-appearing ovarian mass with ascites and elevated serum CA125 levels. • Diagnostic Challenges: The patient’s symptoms, imaging findings, and elevated CA125 levels led to a preliminary diagnosis of ovarian malignancy. The case highlights the difficulty in distinguishing fibro-thecomas from malignant tumors, especially in elderly women. • Demons-Meigs Syndrome: The fibro-thecoma was associated with ascites and pleural effusion, known as Demons-Meigs syndrome. This rare condition can mimic advanced ovarian cancer but resolves following tumor resection. • Postoperative Outcome: The surgery was curative, and no adjuvant therapy was needed. The ascites and pleural effusion resolved after tumor resection, further confirming the benign nature of the tumor. • Conclusion: Radical surgery remains the treatment of choice for fibro-thecomas when malignancy cannot be ruled out. Awareness of Demons-Meigs syndrome is essential to avoid overtreatment and ensure appropriate management of rare ovarian conditions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.hmedic.2025.100327
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.